These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 10696446)

  • 1. A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV: protection studies in different chickens.
    Liu X; Peng D; Wu X; Xing L; Zhang R
    Acta Virol; 1999; 43(2-3):201-4. PubMed ID: 10696446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
    Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
    Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens.
    Heine HG; Foord AJ; Young PL; Hooper PT; Lehrbach PR; Boyle DB
    Virus Res; 1997 Jul; 50(1):23-33. PubMed ID: 9255932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus.
    Lee LE; Witter RL; Reddy SM; Wu P; Yanagida N; Yoshida S
    Avian Dis; 2003; 47(3):549-58. PubMed ID: 14562881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.
    Nazerian K; Lee LF; Yanagida N; Ogawa R
    J Virol; 1992 Mar; 66(3):1409-13. PubMed ID: 1310755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B.
    Omar AR; Schat KA; Lee LF; Hunt HD
    Vet Immunol Immunopathol; 1998 Mar; 62(1):73-82. PubMed ID: 9618870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens.
    Haq K; Fear T; Ibraheem A; Abdul-Careem MF; Sharif S
    Avian Pathol; 2012; 41(1):69-75. PubMed ID: 22845323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
    Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
    Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
    Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNgamma.
    Wang YF; Sun YK; Tian ZC; Shi XM; Tong GZ; Liu SW; Zhi HD; Kong XG; Wang M
    Vaccine; 2009 Nov; 27(50):7046-52. PubMed ID: 19786144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cell line system susceptible to infection with vaccine strains of MDV.
    Abujoub AA; Williams DL; Reilly JD
    Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.